Implant stability with and without platelet-rich fibrin in patients with tooth loss

Implant stability with and without platelet-rich fibrin in patients with tooth loss: a randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N213

Enrollment

Registered

2018-03-15

Start date

2018-03-01

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant stability. Endosseous dental implant failure

Interventions

Intervention 1: Intervention group: The implant with at least diameter of 4 mm and length of 11.5 mm with platelet-rich fibrin. Intervention 2: Control group: The implant with at least diameter of 4 m

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 60 years Having at least 2 teeth lost Enough remaining bone volume for receiving implant with at least diameter of 4 mm and length of 11.5 mm

Exclusion criteria

Exclusion criteria: Any lesion in oral cavity Using immunosuppressive drugs Liver, blood, or renal diseases Pregnancy

Design outcomes

Primary

Measure	Time frame
Implant stability. Timepoint: Immediately after surgery and 1 and 4 weeks after that. Method of measurement: Through physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Ghamari

Hamedan University of Medical Sciences

dr.ghamari@edu.umsha.ac.ir+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026